Nasal And Sinus Decongestant Tablet
NDC Package 73598-1264-1

View Billable Units, 11-Digit Conversion Format, and RxNorm mappings
Table of Contents
    1. Package Information
    2. Frequently Asked Questions

Package Information

Nasal And Sinus Decongestant (phenylephrine hydrochloride) tablets is adults and children 12 years of age and older take 2 tablets every 4 to 6 hours as needed, do not exceed 8 tablets in 24 hours, or as directed by a doctorChildren under 12 years of age: ask a doctor. This formulation utilizes a tablet delivery system. Marketed by Jhk Inc Dba American Safety & First Aid, this product is identified by NDC 73598-1264 and is authorized under FDA application M012.

Identification & Billing

NDC Package Code
73598-1264-1
Package Description
125 PACKET in 1 BOX / 2 TABLET in 1 PACKET
Product Code
73598-1264
11-Digit Billing Format
73598126401
RxNorm Crosswalk

Clinical Specifications

Proprietary Name
Nasal And Sinus Decongestant
Non-Proprietary Name
Phenylephrine Hydrochloride
Substance Name
Phenylephrine Hydrochloride
Dosage Form
Tablet - A solid dosage form containing medicinal substances with or without suitable diluents.
Administration Route
Oral - Administration to or by way of the mouth.
Active Ingredient(s)
PHENYLEPHRINE HYDROCHLORIDE 5 mg/1
Pharmacologic Class
Usage Information
Adults and children 12 years of age and older take 2 tablets every 4 to 6 hours as needed, do not exceed 8 tablets in 24 hours, or as directed by a doctorChildren under 12 years of age: ask a doctor

Regulatory & Marketing

Labeler Name
Jhk Inc Dba American Safety & First Aid
Product Type
Human Otc Drug
FDA Application #
M012
Marketing Category
OTC MONOGRAPH DRUG -
Start Marketing Date
02-02-2000
Listing Expiration
12-31-2026
Exclude Flag
N
Sample Package
No

Hierarchy Structure

Code Lineage

The NDC Directory contains ONLY information on final marketed drugs submitted to FDA electronically by labelers. A labeler might be a manufacturer, re-packager or re-labeler. The product information included in the NDC directory does not indicate that FDA has verified the information provided by the product labeler. Assigned NDC numbers are not in any way an indication of FDA approval of the product.

* Please review the full disclaimer at the bottom of this page.

Frequently Asked Questions

What is the distribution configuration for this product package?

The code 73598-1264-1 identifies a specific commercial package of 125 packet in 1 box / 2 tablet in 1 packet of Nasal And Sinus Decongestant, a human over the counter drug labeled by Jhk Inc Dba American Safety & First Aid. This tablet is formulated for oral use and contains phenylephrine hydrochloride as the active substance.

Is this product currently listed with the FDA?

Yes, this product is active and verified within the NDC Directory. It was introduced to the market by Jhk Inc Dba American Safety & First Aid on February 02, 2000. The current certification is valid through December 31, 2026.

How is this Jhk Inc Dba American Safety & First Aid product billed for insurance claims?

For medical billing and reimbursement, this package follows the 11-digit CMS format: 73598126401. The table below illustrates the segment conversion from the 10-digit labeler code to the 11-digit provider format.

11-Digit Code Conversion

Billing payers usually require a 5-4-2 segment configuration. Below is the conversion from the 10-digit package format to the 11-digit billing format:

10-Digit Format (5-4-1)
73598-1264-1
11-Digit CMS (5-4-2)
73598-1264-01

Note: The zero is added to the Package segment to maintain the 5-4-2 structure.